Cancer Stem Cells Market to Benefit from State Support to Cancer Assistance, Rising Cancer Morbidity Draws Attention from Public Agencies

Due to the rising morbidity and mortality of cancer, research activities for the prevention and treatment of the disease are on the agenda of public health agencies in many countries around the world. Government agencies and healthcare agencies are supporting these initiatives in the form of infrastructural, human resource, and monetary aid.

In this regard, stem cells and cell therapy are slated to have a significant potential for effective cancer treatment. The efficacy of cancer stem cells (CSCs) on animals has been tested with the results obtained being significantly encouraging. However, the efficacy of CSC on humans is still in the testing phase and is facing challenges due to stringent regulatory norms and ethical constraints.

Cancer research studies demonstrate that cancer cells present inside a cancer patient’s body are not all the same. Studies suggest that within a malignant tumor or among cancerous cells that are metastasizing, the cells present are of more than one type. According to the suggestive cancer stem cell theory, among all cancerous cells, only some act as stem cells and have the potency to reproduce themselves and sustain the cancer. This is much like healthy stem cells which have the potency to renew and sustain bodily tissues and organs. In this consideration, cancer stem cells that cannot act as stem cells can also cause problems, however, these cells are not strong enough to sustain an attack on the body in the long run.

Browse Full Report: http://www.transparencymarketresearch.com/cancer-stem-cells-market.html

In the purview of cancer stem cell treatment, cells obtained from a tumor that can reproduce are arranged to multiply in tumors as a separate population, thereby causing deterioration the existing tumor through the development of a new tumor. With advancement in cancer stem cell research, therapies that are specific for cancer of lungs, colorectal, brain, breast, and bones, among others, will improve life-quality of cancer patients and chances of longevity with the disease.

North America is currently the largest market for cancer stem cells – developed research infrastructure, regulatory norms in place, availability of funds, and being home to a large number of skilled researchers and healthcare professionals are the reasons for this.

Some of the major players in the business of cancer stem cells are AdnaGen Gmbh, AVIVA Biosciences Corporation, Epic Sciences Inc., Rarecells USA Inc., Advanced Cell Diagnostics Inc., Celula Inc., Fluxion Biosciences Inc. and Silicon Biosystems, S.p.A.

Cancer Stem Cells Market Trends And Forecast 2014 - 2020

Cancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through generation of new tumor. Thus, with advancement in technology especially in cancer stem cells research area, therapies specific to targeting cancer stem cells are expected to improve quality of life and survival cases of cancer patients with metastatic diseases.

Morbidity and mortality rate of cancer is rising at a faster speed worldwide and thus prevention of cancer and cancer treatment is grabbing attention of cancer researchers globally. Stem cells and cell therapy have shown significant potential to treat cancer effectively. Cancer stem cells (CSCs) have been tested on animal models and have also shown satisfactory results.  However, human testing of cancer stem cells is still in its developing stage owing to stringent regulations and ethical issues associated with the same.

Request a Brochure:  http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2733

Worldwide cancer research activities are increasing rapidly owing to rising burden of mortality rate of cancer. Cancer stem cells are under research for various types of cancers such as lung cancer, breast cancer, colorectal cancer, skin cancer, brain cancer and bone cancer. Government initiative to boost the cancer research activities and availability of funds are some of the factors that are driving the global cancer stem cells (CSCs) market towards growth. While on the other hand, ethical issues involved in the stem cells research and stringent regulations to perform human trials are some of the factors that are restraining the growth of the global cancer stem cells (CSCs) market.

Geographically, global cancer stem cells market is segmented into North America, Europe, Asia Pacific and Rest of the world (RoW) regions. Currently, North America is leading the global cancer stem cells (CSCs) market and is followed by Europe. Factors such as highly developed research infrastructure, well defined regulatory norms, availability of research funds, availability of skilled research and healthcare professionals and supportive economy are driving the North American cancer stem cells market towards growth. Asia Pacific is lucrative market for cancer stem cells. Governments in the Asia Pacific countries mainly, India and China are taking initiative to boost the healthcare and biotechnology industry in the respective countries and thus, research and development activities in these countries are swiftly increasing.

Apart from India and China, Japan will play a significant role in the cancer stem cells market. Japanese government is heavily investing in healthcare industry in order to improve the healthcare facilities in the country and thus rising cancer treatment are expected to escalate the cancer stem cells treatment market in Japan. Latin American countries namely, Brazil, Mexico and Argentina are expected to contribute more to cancer stem cells market than other countries in the rest of the world region. While on the other hand, African countries and Middle Eastern countries are expected to show slow or no growth rate in the global cancer stem cells (CSCs) market.

Some of the major players in the global cancer stem cells market are AdnaGen GmbH, Advanced Cell Diagnostics, Inc., AVIVA Biosciences Corporation, Celula, Inc., Epic Sciences, Inc., Fluxion Biosciences, Inc., Rarecells USA, Inc. and Silicon Biosystems, S.p.A.

Know more: http://www.transparencymarketresearch.com/cancer-stem-cells-market.html